Discontinuation report LESCOL XL
| Report ID | 109153 |
| Drug Identification Number | 02250527 |
| Brand name | LESCOL XL |
| Common or Proper name | LESCOL XL 80MG 2X14 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | FLUVASTATIN |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 2X14 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2020-04-03 |
| Actual discontinuation date | 2020-04-03 |
| Remaining supply date | 2020-04-03 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-04-17 | French | Compare |
| v3 | 2020-04-17 | English | Compare |
| v2 | 2020-03-20 | French | Compare |
| v1 | 2020-03-20 | English | Compare |
Showing 1 to 4 of 4